Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme …
Biotechnology
US, Cambridge [HQ]
Lobbying Analysis
Lobbying · US Senate · Influence
Infinity Pharmaceuticals, Inc. has no lobbying expenses in our database.
History
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
No data |